Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines

Jimmy J. Caudell; Maura L. Gillison; Ellie Maghami; Sharon Spencer; David G. Pfister; Douglas Adkins; Andrew C. Birkeland; David M. Brizel; Paul M. Busse; Anthony J. Cmelak; A. Dimitrios Colevas; David W. Eisele; Thomas Galloway; Jessica L. Geiger; Robert I. Haddad; Wesley L. Hicks; Ying J. Hitchcock; Antonio Jimeno; Debra Leizman; Loren K. Mell; Bharat B. Mittal; Harlan A. Pinto; James W. Rocco; Cristina P. Rodriguez; Panayiotis S. Savvides; David Schwartz; Jatin P. Shah; David Sher; Maie St. John; Randal S. Weber; Gregory Weinstein; Frank Worden; Justine Yang Bruce; Sue S. Yom; Weining Zhen; Jennifer L. Burns; Susan D. Darlow

doi:10.6004/JNCCN.2022.0016

Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines

Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Thomas Galloway, Jessica L. Geiger, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra Leizman, Loren K. MellBharat B. Mittal, Harlan A. Pinto, James W. Rocco, Cristina P. Rodriguez, Panayiotis S. Savvides, David Schwartz, Jatin P. Shah, David Sher, Maie St. John, Randal S. Weber, Gregory Weinstein, Frank Worden, Justine Yang Bruce, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan D. Darlow

Radiation Oncology

Research output: Contribution to journal › Review article › peer-review

252 Scopus citations

Abstract

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

Original language	English (US)
Pages (from-to)	225-234
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	20
Issue number	3
DOIs	https://doi.org/10.6004/JNCCN.2022.0016
State	Published - Mar 2022

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/JNCCN.2022.0016

Cite this

Caudell, J. J., Gillison, M. L., Maghami, E., Spencer, S., Pfister, D. G., Adkins, D., Birkeland, A. C., Brizel, D. M., Busse, P. M., Cmelak, A. J., Colevas, A. D., Eisele, D. W., Galloway, T., Geiger, J. L., Haddad, R. I., Hicks, W. L., Hitchcock, Y. J., Jimeno, A., Leizman, D., ... Darlow, S. D. (2022). Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 20(3), 225-234. https://doi.org/10.6004/JNCCN.2022.0016

@article{0f114b5e01784b07a04c64f3c7d99f55,

title = "Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel{\textquoteright}s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.",

author = "Caudell, {Jimmy J.} and Gillison, {Maura L.} and Ellie Maghami and Sharon Spencer and Pfister, {David G.} and Douglas Adkins and Birkeland, {Andrew C.} and Brizel, {David M.} and Busse, {Paul M.} and Cmelak, {Anthony J.} and Colevas, {A. Dimitrios} and Eisele, {David W.} and Thomas Galloway and Geiger, {Jessica L.} and Haddad, {Robert I.} and Hicks, {Wesley L.} and Hitchcock, {Ying J.} and Antonio Jimeno and Debra Leizman and Mell, {Loren K.} and Mittal, {Bharat B.} and Pinto, {Harlan A.} and Rocco, {James W.} and Rodriguez, {Cristina P.} and Savvides, {Panayiotis S.} and David Schwartz and Shah, {Jatin P.} and David Sher and {St. John}, Maie and Weber, {Randal S.} and Gregory Weinstein and Frank Worden and Bruce, {Justine Yang} and Yom, {Sue S.} and Weining Zhen and Burns, {Jennifer L.} and Darlow, {Susan D.}",

year = "2022",

month = mar,

doi = "10.6004/JNCCN.2022.0016",

language = "English (US)",

volume = "20",

pages = "225--234",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

Caudell, JJ, Gillison, ML, Maghami, E, Spencer, S, Pfister, DG, Adkins, D, Birkeland, AC, Brizel, DM, Busse, PM, Cmelak, AJ, Colevas, AD, Eisele, DW, Galloway, T, Geiger, JL, Haddad, RI, Hicks, WL, Hitchcock, YJ, Jimeno, A, Leizman, D, Mell, LK, Mittal, BB, Pinto, HA, Rocco, JW, Rodriguez, CP, Savvides, PS, Schwartz, D, Shah, JP, Sher, D, St. John, M, Weber, RS, Weinstein, G, Worden, F, Bruce, JY, Yom, SS, Zhen, W, Burns, JL & Darlow, SD 2022, 'Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 3, pp. 225-234. https://doi.org/10.6004/JNCCN.2022.0016

TY - JOUR

T1 - Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines

AU - Caudell, Jimmy J.

AU - Gillison, Maura L.

AU - Maghami, Ellie

AU - Spencer, Sharon

AU - Pfister, David G.

AU - Adkins, Douglas

AU - Birkeland, Andrew C.

AU - Brizel, David M.

AU - Busse, Paul M.

AU - Cmelak, Anthony J.

AU - Colevas, A. Dimitrios

AU - Eisele, David W.

AU - Galloway, Thomas

AU - Geiger, Jessica L.

AU - Haddad, Robert I.

AU - Hicks, Wesley L.

AU - Hitchcock, Ying J.

AU - Jimeno, Antonio

AU - Leizman, Debra

AU - Mell, Loren K.

AU - Mittal, Bharat B.

AU - Pinto, Harlan A.

AU - Rocco, James W.

AU - Rodriguez, Cristina P.

AU - Savvides, Panayiotis S.

AU - Schwartz, David

AU - Shah, Jatin P.

AU - Sher, David

AU - St. John, Maie

AU - Weber, Randal S.

AU - Weinstein, Gregory

AU - Worden, Frank

AU - Bruce, Justine Yang

AU - Yom, Sue S.

AU - Zhen, Weining

AU - Burns, Jennifer L.

AU - Darlow, Susan D.

PY - 2022/3

Y1 - 2022/3

N2 - The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

AB - The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

UR - http://www.scopus.com/inward/record.url?scp=85126388917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126388917&partnerID=8YFLogxK

U2 - 10.6004/JNCCN.2022.0016

DO - 10.6004/JNCCN.2022.0016

M3 - Review article

C2 - 35276673

AN - SCOPUS:85126388917

SN - 1540-1405

VL - 20

SP - 225

EP - 234

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this